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Immunohistochemical studies 222
Immunohistochemical staining were performed on 5 μm 4% paraformaldehyde-fixed 223 and paraffin-embedded lung sections using the Dako Autostainer (DAKO Corp., 224
Carpinteria, CA) with rabbit anti-WR primary antibody. After incubation with the 225 secondary antibodies, positive cells were visualized using 3,3-diaminobenzidine 226 tetrahydrochloride plus as a chromogen. All sections were counterstained with 227 hematoxylin. Images were taken using a Zeiss Axiophot microscope (Carl Zeiss  228 Microimaging GmbH, Gottingen, Germany), converted into standard TIFF format and 229 analyzed with the Nikon Digital Sight software. 230
Growth Curves 231
To determine virus yields produced intracellularly and released from cells in the 232 different cell lines, confluent CEF, HeLa or 3T3 cells grown in 24-well plates were 233 infected in duplicates with a MOI of 0.01 or 5 pfu/cell. At 6, 24 and 48 hpi, cells were 234 recovered from the well, freeze-thawed three times, sonicated and virus titration was 235 performed in BSC40 cells as previously described (21 L.amazonensis promastigotes resuspended in 10 μl using BD Micro-Fine (BD 264 Biosciences) 0.5 ml 30G needles. 265
Intracellular Cytokine Staining assay (ICS) 266
The phenotypes of responding T cells were analyzed by ICS and fluorescence-activated 267 cell sorting analysis as described elsewhere (26). After an overnight rest, 5x10 peptide or 5x10 5 A20 cells nucleofected with pCIneo-LACK plasmid (using a 4D 270 nucleofector, LONZA, Germany) during 6 hours in RPMI 1640 medium supplemented 271 with 10% FCS and containing 1 μl/well Golgiplug (BD Biosciences) to inhibit cytokine 272 secretion. After stimulation, cells were washed, stained for the surface markers, fixed, 273 permeabilized using the BD Cytofix/Cytoperm™ Kit (Becton Dickinson) and stained 274 intracellularly using the appropriate fluorochromes. For memory analyses, the following 275 antibodies were used: CD4-Alexa 700, CD8-V500, CD62L-FITC, CD44-SPRD, 276 CD127-PECy5.5, IFN -PECy-7, TNF -PE and IL-2-APC. All antibodies were from 277 BD Biosciences. Cells were acquired using an LSRII flow cytometer (Becton 278
Dickinson) equipped with a high throughput system. The number of events ranged 279 between 10 5 and 10 6 . Dead cells were excluded using the violet LIVE/DEAD stain kit 280 Table I and Table II, showed the same two mutations in both viruses: D23N, present in conserved BCL-2 α2 500 domain and G84C present at the end of α5 domain. 501 M1L deletion is enough to attenuate VACV (49) and share 3 missense mutations in both 502 viruses (H130Q, N131H and F377S). B18R gene that encodes for type I interferon 503 binding protein (50), presents I293M mutation in both viruses and an extra mutation in 504 M101 (L468N). In addition to those genes, M65 virus present two missense mutations 505 (A15D and K21N) in F7L, a gene that encodes for 3 beta-hydroxysteroid 506 dehydrogenase whose deletion causes attenuation in vivo (51). 507
Mutations in genes involved in DNA replication and transcription. 508
Some missense mutations were found in genes involved in DNA synthesis, replication 509 or transcription, most of them present in the central region of the genome. K4L that 510 encodes for vaccinia nicking-joining enzyme (52), presents one mutation in M65 511 (A265S) and two in M101 (L35V and A265S). E1L gene, encoding for PAP Poly A 512
Polymerase VP-55 (53), contains 3 identical mutations in both viruses (L10F, N68D, 513 R199L). Nuclease G5R (54), presents also identical missense mutations in both viruses 514 on January 1, 2018 by guest http://jvi.asm.org/ Downloaded from (E124K and N254T). G8R that encodes structural orthologs of proliferating cell nuclear 515 antigen (55), present one missense mutation in M65 (A187V) and two in M101 (A87V 516 and N224D). I8R the gene encoding DNA and RNA helicases (56) contains one 517 mutation in M65 (N217D) and two in M101 genome (N217D and D296Y). L3L gene 518 encodes a transcription factor for early genes (57), and present two mutations in both 519 viruses (Q34K and I275T). H4L RNA polymerase (58) present two different mutations 520 in M101 genome (Y623C and I624V). H5R late gene transcription factor (59) that is 521 phosphorilated in threonine residue by B1R complex (60), showed one missense 522 mutation in both viruses (R53G) and M101 mutant presented another missense mutation 523 in one threonine (T15A). 524 and long-term, were designed for the challenge with the parasites: 5x10 4 metacyclic 542 promastigotes of L. major inoculated 3 weeks or 8 weeks after the booster (Fig. 7,  543 panels A and B), and follow lesion size weekly as described previously (18). 544
Recombinants based on M65 and M101 mutant viruses elicit protection in a 525

Leishmania-mouse model of infection
In the short-term challenge (Fig 7A) , with parasite inoculation 3 weeks after vector 545 booster, there is 42% reduction in lesion size in the group that received DNA- (Fig. 7D) . 628
The overall antibody levels in sera specific for VACV proteins were slightly reduced in 629 the recombinant vector MVA versus the mutant viruses M65 and M101 (Fig 8E) . 630
The above findings showed that, at the memory phase, both polyfunctional CD4 + and 631 Comparison between virus strains of the different genes deleted in the right-end of the 688 genome is summarized in Fig. 6B . 689
The key biological differences between M65 and M101 could be explained by the 690 increased number of missense mutations present in M101 genome, particularly in genes 691 involved in virus entry, or in late morphogenesis and plaque size. Although none of the 692 particular mutations identified in those genes have been described as crucial for virus 693 replication, it remains to be determined the particular roles of different mutations in 694 virus-host cell interactions, morphogenesis and plaque size. In the later case, A34R 695 showed a missense mutation in its natural stop codon that can provide, in part, an 696 explanation for the smaller plaque size mentioned in Table III , and on the in vivo 697 attenuation findings. 698
It is significant that the viral gene K3L, involved in the inhibition of the antiviral protein 699 kinase PKR (71) remained intact after over 100 passages, indicating the likely 700 requirement of these two genes to counteract the host antiviral response for the viruses 701 to remain viable. In this regard, it has been described recently the phenomenon of 702 
